SCHEMBL15510464

SCHEMBL15510464

O=C(ON1CCOCC1)O[SH](=O)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALOX15 P16050 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA9 Q16790 1/20 0.33
KMT2A Q03164 2/20 0.32
TP53 P04637 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
USP2 O75604 1/20 0.32
KDM4E B2RXH2 2/20 0.31
MMP1 P03956 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4018378 0.83 L3MBTL1 (0.41) TSHRHSD17B10L3MBTL1ALOX15SMN1; SMN2
Ammonia Solution, Strong SCHEMBL9998480 0.81 L3MBTL1 (0.40) TSHRHSD17B10L3MBTL1ALOX15SMN1; SMN2
SCHEMBL15510710 0.79 ALDH1A1 (0.31) ALDH1A1
SCHEMBL28135695 0.75 ALDH1A1 (0.43) TSHRHSD17B10ALOX15SMN1; SMN2KMT2A
SCHEMBL3822896 0.73 L3MBTL1 (0.41) TSHRHSD17B10L3MBTL1ALOX15SMN1; SMN2
SCHEMBL30113134 0.72 TSHR (0.38) TSHRHSD17B10L3MBTL1ALOX15SMN1; SMN2
SCHEMBL15511311 0.72 L3MBTL1 (0.34) TSHRHSD17B10L3MBTL1ALOX15SMN1; SMN2
SCHEMBL4695520 0.72 HSD17B10 (0.41) TSHRHSD17B10L3MBTL1ALOX15SMN1; SMN2
SCHEMBL28170554 0.71 TSHR (0.52) TSHRL3MBTL1SMN1; SMN2CA12CA1
SCHEMBL249323 0.70 SMN1; SMN2 (0.48) TSHRHSD17B10L3MBTL1SMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-23 US claimed
EP-2888044-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-01 EP claimed
WO-2014031956-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2014-02-27 WO claimed
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. 2023-08-17 US disclosed
EP-4209130-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-12 EP disclosed
EP-4205553-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-05 EP disclosed
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-05-23 US disclosed
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-02-21 US disclosed
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE DSM NUTRITIONAL PRODUCTS, LLC 2022-12-29 US disclosed
US-20220400728-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF CADENA BIO INC (US) 2022-12-22 US disclosed
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF HERCULES CAPITAL, INC. 2021-11-18 US disclosed
WO-2016122940-A1 METHODS OF PRODUCING ANHYDROSUGAR ALCOHOLS MIDORI USA, INC. (US) 2016-08-04 WO disclosed
WO-2016122884-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. (US) 2016-08-04 WO disclosed
US-9238845-B2 Methods of producing sugars from biomass feedstocks MIDORI USA, INC. (US) 2016-01-19 US disclosed
US-20160007642-A1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF MIDORI USA, INC. (US) 2016-01-14 US disclosed
WO-2016007778-A1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF MIDORI USA, INC. (US) 2016-01-14 WO disclosed
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-23 US disclosed
EP-2888044-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-01 EP disclosed
US-20140060522-A1 METHODS OF PRODUCING SUGARS FROM BIOMASS FEEDSTOCKS HERCULES CAPITAL, INC. 2014-03-06 US disclosed
WO-2014031956-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2014-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF FUT5, FUT6, OSTC TSHR 3824/4885HSD17B10 1760/4885L3MBTL1 3536/4885
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof OSTC, FUT5, FUT6 TSHR 4153/4885HSD17B10 1297/4885L3MBTL1 4336/4885
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof FUT5, FUT6, OSTC TSHR 3824/4885HSD17B10 1760/4885L3MBTL1 3536/4885
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE FUT6, FUT5, PIGS TSHR 2721/4885HSD17B10 2575/4885L3MBTL1 2569/4885
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF OSTC, FUT5, FUT6 TSHR 4762/4885HSD17B10 1674/4885L3MBTL1 4290/4885
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS MGAM, CEL, SI TSHR 4779/4885HSD17B10 909/4885L3MBTL1 3866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.